SCHEMBL16236389

SCHEMBL16236389

CC(Oc1ccccc1)c1nccc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.51
▸ POLB P06746 2/20 0.51
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ NCOA3 Q9Y6Q9 1/20 0.45
▸ CYP2A6 P11509 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ MAPT P10636 3/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ ADRA2B P18089 1/20 0.42
▸ ADRA2C P18825 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ NISCH Q9Y2I1 1/20 0.42
▸ F12 P00748 1/20 0.41
▸ PLAU P00749 1/20 0.41
▸ NCF1 P14598 1/20 0.41
▸ NOS3 P29474 1/20 0.41
▸ NOS1 P29475 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9097174 0.80 LMNA (0.48) LMNAPOLBNPC1RAB9ANCOA3
SCHEMBL1102399 0.79 LMNA (0.59) LMNANPC1RAB9ANCOA3CYP2A6
SCHEMBL31732807 0.79 LMNA (0.59) LMNANPC1RAB9ANCOA3CYP2A6
SCHEMBL10545951 0.78 LMNA (0.46) LMNANPC1RAB9ANCOA3CYP2A6
Iodide SCHEMBL10722209 0.77 LMNA (0.58) LMNANPC1RAB9ANCOA3CYP2A6
SCHEMBL7073970 0.75 LMNA (0.65) LMNANPC1RAB9ANCOA3CYP2A6
SCHEMBL19099919 0.74 LMNA (0.54) LMNANPC1RAB9ANCOA3CYP2A6
SCHEMBL6638130 0.74 LMNA (0.54) LMNANPC1RAB9ANCOA3CYP2A6
SCHEMBL4265753 0.74 LMNA (0.64) LMNANPC1RAB9ANCOA3CYP2A6
SCHEMBL6748371 0.74 LMNA (0.54) LMNANPC1RAB9ANCOA3CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997015-B1 PHENOXYETHYL DIHYDRO-1H-ISOQUINOLINE COMPOUNDS LILLY CO ELI (US) 2017-04-05 — — EP disclosed
US-9371289-B2 Phenoxyethyl dihydro-1H-isoquinoline compounds ELI LILLY AND COMPANY (US) 2016-06-21 — — US disclosed
EP-2997015-A1 PHENOXYETHYL DIHYDRO-1H-ISOQUINOLINE COMPOUNDS Eli Lilly and Company (US) 2016-03-23 — — EP disclosed
US-20160052889-A1 PHENOXYETHYL DIHYDRO-1H-ISOQUINOLINE COMPOUNDS JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT 2016-02-25 — — US disclosed
CN-105209438-A Phenoxyethyl dihydro-1H-isoquinoline compounds LILLY CO ELI 2015-12-30 — — CN disclosed
WO-2014186218-A1 PHENOXYETHYL DIHYDRO-1H-ISOQUINOLINE COMPOUNDS ELI LILLY AND COMPANY (US) 2014-11-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160052889-A1 PHENOXYETHYL DIHYDRO-1H-ISOQUINOLINE COMPOUNDS REN, NHERF1, KCNH1 LMNA 3301/4885POLB 2318/4885NPC1 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback